FDA Adverse Event Death Summary report: N

MEDTRONIC EVOLUT TRANSCATHETER AORTIC VALVE

MDR report key: 19937852 · Received August 6, 2024

Report

Report Number
MW5158126
Event Type
Death
Date Received
August 6, 2024
Date of Event
July 12, 2024
Report Date
August 5, 2024
Manufacturer
MEDTRONIC MEXICO S. DE R.L. DE CV
Product Code
NPT
Adverse Event
Yes
Report Source
Voluntary report
Reporter Location
CA, US
Reporter Occupation
UNKNOWN
Health Professional
*

Narratives

Description of Event or Problem · 0

AS REPORTED BY THE FIELD CLINICAL SPECIALIST (FCS), THE PATIENT HAD A BAILOUT PROCEDURE WITH A MEDTRONIC (NON-(B)(6)) EVOLUT; AFTER SEVERAL RECAPTURES, THE PATIENT CODED ON THE TABLE. A 29MM SAPIEN 3 VALVE WAS THEN IMPLANTED IN THE NATIVE AORTIC POSITION VIA TRANSCAROTID APPROACH. POST TAVR, THE PATIENT HAD MULTIPLE COMPLICATIONS FROM THE PROLONGED CPR (CARDIOPULMONARY RESUSCITATION), TRACHEOSTOMY, PEG (PERCUTANEOUS ENDOSCOPIC GASTROSTOMY) TUBE PLACEMENT, PERMANENT PACEMAKER, MULTIPLE PRESSORS FOR BEING IN SHOCK, AND NEW DIALYSIS. THE PATIENT PASSED AWAY AFTER A PROGRESSIVE DECLINE. THERE WAS NO ALLEGATION OF AN (B)(6) DEVICE DEFICIENCY. THIS REPORT REFLECTS INFORMATION RECEIVED BY FDA IN THE FORM OF A NOTIFICATION PER 803.22 (B)(2).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1636139 MEDTRONIC EVOLUT TRANSCATHETER AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC MEXICO S. DE R.L. DE CV

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Death